| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-13 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-09 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-09 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-08 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-08 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-08 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-08 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-07 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |